Correlation Between CERo Therapeutics and Invizyne Technologies

Can any of the company-specific risk be diversified away by investing in both CERo Therapeutics and Invizyne Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CERo Therapeutics and Invizyne Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CERo Therapeutics Holdings and Invizyne Technologies Common, you can compare the effects of market volatilities on CERo Therapeutics and Invizyne Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CERo Therapeutics with a short position of Invizyne Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of CERo Therapeutics and Invizyne Technologies.

Diversification Opportunities for CERo Therapeutics and Invizyne Technologies

-0.31

Correlation Coefficient

CERo Therapeutics  Invizyne Technologies

Very good diversification

The 3 months correlation between CERo and Invizyne is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding CERo Therapeutics Holdings and Invizyne Technologies Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invizyne Technologies and CERo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CERo Therapeutics Holdings are associated (or correlated) with Invizyne Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invizyne Technologies has no effect on the direction of CERo Therapeutics i.e., CERo Therapeutics and Invizyne Technologies go up and down completely randomly.

Pair Corralation between CERo Therapeutics and Invizyne Technologies

Assuming the 90 days horizon CERo Therapeutics is expected to generate 1.03 times less return on investment than Invizyne Technologies. In addition to that, CERo Therapeutics is 3.64 times more volatile than Invizyne Technologies Common. It trades about 0.1 of its total potential returns per unit of risk. Invizyne Technologies Common is currently generating about 0.37 per unit of volatility. If you would invest  865.00  in Invizyne Technologies Common on September 14, 2024 and sell it today you would earn a total of  696.00  from holding Invizyne Technologies Common or generate 80.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	13.38%
Values	Daily Returns

CERo Therapeutics Holdings  vs.  Invizyne Technologies Common

CERo Therapeutics

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Invizyne Technologies

Risk-Adjusted Performance

29 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Invizyne Technologies Common are ranked lower than 29 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Invizyne Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CERo Therapeutics and Invizyne Technologies

The main advantage of trading using opposite CERo Therapeutics and Invizyne Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CERo Therapeutics position performs unexpectedly, Invizyne Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invizyne Technologies will offset losses from the drop in Invizyne Technologies' long position.

The idea behind CERo Therapeutics Holdings and Invizyne Technologies Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.